Louise B. Lawson

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

Elizabeth B. Norton, Louise B. Lawson, Lucy C. Freytag et al. · Clinical and Vaccine Immunology · 2011 · 219 citations · Full text

The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens

Elizabeth B. Norton, Louise B. Lawson, Zaid Mahdi et al. · Infection and Immunity · 2012 · 98 citations · Full text

Microbial Toxin, Mucosal Vaccination, Enterotoxigenic Escherichia Coli +15

Hydration Effects on Skin Microstructure as Probed by High-Resolution Cryo-Scanning Electron Microscopy and Mechanistic Implications to Enhanced Transcutaneous Delivery of Biomacromolecules

Grace Tan, Peng Xu, Louise B. Lawson et al. · Journal of Pharmaceutical Sciences · 2009 · 89 citations · Full text

Tissue Engineering, Engineering, Biomaterials Design +6

The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model

Elizabeth B. Norton, David L. Bauer, William C. Weldon et al. · Vaccine · 2015 · 76 citations · Full text

Internal Coalescence as a Mechanism of Instability in Water-in-Oil-in-Water Double-Emulsion Globules

Carlos H. Villa, Louise B. Lawson, Yimin Li et al. · Langmuir · 2002 · 61 citations

Engineering, Liquid-liquid Flow, Fluid Mechanics +20